Opinion Insurance, Not Regulation, May Be the Next Frontier for Psychedelic Medicine by Psychedelics.Media Team August 7, 2026
Compass Pathways Reports Positive Six-Month Phase 3 Results for Psilocybin Therapy in Treatment-Resistant Depression July 10, 2026